Delivery Order SPE2DB25D3020-SPE2DB25FWFZZ
Award Date
2/19/25
Potential Completion Date
2/20/25
Potential Value
$19K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Repatha 140 mg/ml syringes to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,083.88, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order issued under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $13,147.05, is for the delivery of Repatha 140 mg/mL syringes. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Repatha 140 mg/mL syringes to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,016.82 firm-fixed-price delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities. As the prime contractor, Amerisourcebergen will...
This federal contract award is for pharmaceutical products, specifically Repatha 140 mg/ml SureClick injections, with a ceiling value of $6,854.41. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA), a defense agency. The contract is a delivery order, with a firm-fixed price pricing type, and has an ultimate completion date of November 22, 2024. There is no set-aside designation,...
This federal contract award is for the delivery of Repatha 140 mg/ml SureClick syringes, a specialty pharmaceutical medication, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $2,859.27 and an ultimate completion date of August 14, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the...
This federal contract award, valued at $3,537.84, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Repatha 140 mg/ml syringes, a specialty medication used for cardiovascular health. The contract has an ultimate completion date of July 11, 2023 and is a Firm Fixed Price agreement. This award is likely part of a larger Indefinite Delivery Contract...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Repatha 140 mg/ml syringes. The contract, valued at $3,298.59, is a Firm Fixed Price Delivery Order issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. The award has a completion date of September 9, 2024. AmerisourceBergen, through its Corporate Office Division, has been awarded this contract to supply this critical specialty medication to...
This federal contract award, valued at $8,893.10, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Repatha 140 mg/ml syringes, a cardiovascular medication. This is a firm-fixed-price Delivery Order contract with a completion date of February 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a larger Indefinite Delivery Contract...
The federal contract award is for the pharmaceutical product Repatha 140 mg/ml SureClick, with a total ceiling value of $1,753.30. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type, with a period of performance running through February 2025. The contract does not have a set-aside designation, indicating open competition....
This federal contract award is for the pharmaceutical product Repatha 140 mg/ml syringe. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The contract has a ceiling value of $1,016.76 and is a delivery order with a firm fixed price. Amerisourcebergen Drug Corp is a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. The company has...